Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Procter & Gamble (PG)

P&G Q4 diluted EPS fell 15%; FY2027 core EPS guided in-line to up 3%

Mixed Impact 3 of 5 earnings Written later

Procter & Gamble reported fourth-quarter and fiscal 2026 results for the quarter ended June 30, 2026. Quarterly diluted EPS fell 15% to $1.26 even as net sales rose 2%, while full-year sales and EPS grew, and the company gave fiscal 2027 growth guidance.

Key points

  • Q4 net sales were $21.2 billion, up 2%, with organic sales unchanged; diluted EPS was $1.26, down 15%, and core EPS was $1.43, down 3%.
  • Fiscal 2026 net sales were $87.0 billion, up 3%; diluted EPS was $6.62, up 2%; core EPS was $6.89, up 1%.
  • Fiscal 2027 guidance: all-in sales growth of 1% to 3%, diluted EPS growth of 1% to 5%, and core EPS growth in-line to 3%, or $6.89 to $7.11 per share.
  • P&G returned over $15 billion to shareholders in fiscal 2026, including $10.2 billion in dividends and $5.0 billion in share repurchases.

The filing

CompanyProcter & Gamble (PG)
Form8-K, current report
Filed with the SECJul 29, 2026, 7:03 AM ET
Accession number0000080424-26-000093

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 2:16 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 29, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.